Related Experiment Video

Updated: May 11, 2026

Mouse Kidney Transplantation: Models of Allograft Rejection
16:15

Mouse Kidney Transplantation: Models of Allograft Rejection

Published on: October 11, 2014

Pathophysiology and treatment options of chronic renal allograft damage

Uwe Heemann1, Jens Lutz

  • 1Department of Nephrology, Klinikum rechts der Isar, München, Germany.

Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
|April 30, 2013
PubMed

Insights

Chronic rejection remains a major cause of graft failure, with current treatments showing limited success. Early angiotensin-converting enzyme (ACE)/AT1 blocker use may benefit graft survival, though optimal immunosuppression strategies require further investigation.

Area of Science:

  • Nephrology
  • Immunology
  • Transplantation Medicine

Background:

  • Chronic rejection frequently leads to graft failure despite advancements in immunosuppression.
  • The exact mechanisms driving chronic graft destruction are not fully understood.
  • Hypotheses include ongoing rejection, antibody-mediated rejection, organ quality, hyperfiltration, calcineurin inhibitor (CNI) nephrotoxicity, and non-compliance, likely acting in concert.

Purpose of the Study:

  • To review the pathophysiological aspects of chronic allograft damage.
  • To explore potential treatment options for mitigating chronic rejection.
  • To highlight the complexities and current understanding of graft failure.

Main Methods:

  • Literature review of pathophysiological mechanisms.
  • Analysis of existing hypotheses for chronic graft destruction.
  • Discussion of current and potential therapeutic strategies.

Main Results:

  • No single hypothesis fully explains chronic graft destruction; a combination of factors is probable.
  • Early treatment with angiotensin-converting enzyme (ACE)/AT1 blockers appears beneficial.
  • The impact of reducing or switching calcineurin inhibitors (CNIs) on graft survival remains unclear.

Conclusions:

  • Chronic allograft damage is multifactorial, necessitating a comprehensive understanding of its pathophysiology.
  • Targeting specific pathways, such as with ACE/AT1 blockers, shows promise.
  • Further research is needed to optimize immunosuppressive regimens and improve long-term graft survival.
Keywords:
chronic allograft nephropathychronic rejectionpathophysiologytreatment

Related Concept Videos

Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...